✦ LIBER ✦

373 Phase II trial of letrozole (a novel oral nonsteroidal aromatase inhibitor) in postmenopausal patients with advanced or recurrent breast cancer

✍ Scribed by T. Tominaga; Y. Ohashi; R. Abe; M. Yoshida; H. Koyama; Y. Nomura; A.S. Bhatnagar

Book ID: 116167128
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 153 KB
Volume: 31
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(95)95626-h

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Activity of megestrol acetate in postmen

Activity of megestrol acetate in postmenopausal women with advanced breast cancer after nonsteroidal aromatase inhibitor failure: a phase II trial

✍ Bines, J.; Dienstmann, R.; Obadia, R. M.; Branco, L. G. P.; Quintella, D. C.; Ca 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 170 KB

A phase II study of a potent and selecti

A phase II study of a potent and selective aromatase inhibitor, anastrozole (ZD-1033), in Japanese postmenopausal women with advanced/recurrent breast cancer

✍ H. Koyama 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Randomized Phase III Placebo-Controlled

Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

✍ Wolff, A. C.; Lazar, A. A.; Bondarenko, I.; Garin, A. M.; Brincat, S.; Chow, L.; 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 194 KB

The oral mTOR inhibitor RAD001 (everolim

The oral mTOR inhibitor RAD001 (everolimus) in combination with letrozole in patients with advanced breast cancer: Results of a phase I study with pharmacokinetics

✍ Ahmad Awada; Fatima Cardoso; Christel Fontaine; Luc Dirix; Jacques De Grève; Chr 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 175 KB

A phase II trial of arzoxifene, a select

A phase II trial of arzoxifene, a selective estrogen response modulator, in patients with recurrent or advanced endometrial cancer

✍ D.Scott McMeekin; Alan Gordon; Jeffrey Fowler; Allen Melemed; Richard Buller; Th 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 71 KB

A randomized, phase III trial exploring

A randomized, phase III trial exploring the effects of neoadjuvant sequential treatment with steroidal (exemestane) and nonsteroidal (anastrozole) aromatase inhibitors on biomarkers in postmenopausal women with hormone receptor-positive locally advanced breast cancer

✍ OC Freedman, E Amir, G Dranitsaris, M Dowsett, DEC Cole, H Kahn… 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 461 KB